Naima Nur | Microbiology | Best Researcher Award

Published on by Medical Lab Scientist

Best Researcher Award

Naima Nur
Management Science Research Centre, Bangladesh
Naima Nur
Affiliation Management Science Research Centre
Country Bangladesh
Scopus ID 57297459000
Documents 5
Citations 100
h-index 3
Subject Area Microbiology
Event Medical Lab Scientist Awards
ORCID 0000-0002-6695-5294

The Best Researcher Award recognizes the scholarly contributions and research activities of Naima Nur, affiliated with the Management Science Research Centre in Bangladesh. The recognition highlights research engagement within the field of microbiology and related interdisciplinary scientific investigations. The award is associated with the Medical Lab Scientist Awards platform, which acknowledges academic achievement, publication impact, and research dissemination within laboratory and biomedical sciences.[1] The research profile demonstrates measurable scholarly activity through indexed publications, citations, and international research visibility.[2]

Abstract

The Best Researcher Award profile of Naima Nur presents an overview of academic contributions associated with microbiology and laboratory-based scientific studies. The profile demonstrates participation in peer-reviewed publication activities and measurable scholarly metrics indexed through Scopus databases. Research visibility is reflected through citation accumulation, indexed documents, and collaborative scientific dissemination.[2] The award recognition aligns with international standards emphasizing publication quality, scientific relevance, and contribution to medical laboratory sciences.[3]

Keywords

Microbiology, Medical Laboratory Science, Research Recognition, Scientific Publications, Citation Analysis, Scopus Indexed Research

Introduction

Academic recognition awards are widely used to acknowledge scholarly productivity, scientific innovation, and contributions to specialized research domains. Within microbiology and medical laboratory sciences, awards frequently consider publication quality, research impact, and interdisciplinary relevance.[4] Naima Nur’s academic profile demonstrates engagement with internationally indexed research dissemination and scientific communication through peer-reviewed outputs and citation activity.[1]

Research Profile

Naima Nur is affiliated with the Management Science Research Centre in Bangladesh and has contributed to microbiology-oriented academic investigations. The research profile indexed under Scopus Author ID 57297459000 includes multiple scholarly publications with measurable citation activity.[1] Bibliometric indicators such as document count, citation frequency, and h-index are commonly used to evaluate academic visibility and research continuity within scientific communities.[1]

Research Contributions

The research contributions associated with Naima Nur include participation in scientific discussions related to microbiological methodologies, laboratory practices, and biomedical analytical frameworks. Research dissemination through indexed journals contributes to evidence-based scientific communication and enhances the accessibility of microbiological findings.[5]

Publications

The publication record associated with the researcher reflects participation in peer-reviewed academic dissemination. Indexed publications within microbiology and associated biomedical sciences support the visibility of scientific findings and contribute to citation-based evaluation metrics.[5]

Research Impact

Research impact is often evaluated through citations, scholarly engagement, and dissemination across international indexing systems. The citation profile associated with Naima Nur indicates that published works have contributed to ongoing academic referencing activities.[3] Citation-based indicators provide measurable evidence of research visibility and scientific interaction within the broader microbiology research community.[2]

Award Suitability

The Best Researcher Award recognition is aligned with measurable academic indicators including indexed publications, citation performance, and documented research engagement. The scholarly profile of Naima Nur demonstrates research participation relevant to microbiology and laboratory science disciplines.[1]

Conclusion

The Best Researcher Award profile of Naima Nur reflects academic participation in microbiology-related research and scholarly communication. Indexed publications, citation metrics, and affiliation with recognized research institutions collectively support the visibility of the research profile within international scientific databases.[2] The recognition associated with the Medical Lab Scientist Awards platform highlights contributions to laboratory science and the broader scientific research community.[5]

References

  1. Elsevier. (n.d.). Scopus author details: Naima Nur, Author ID 57297459000. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=57297459000
  2. Pathogens (20226). Patterns of Multidrug Resistance and Treatment Outcomes Among Pulmonary Tuberculosis Patients in Bangladesh. https://doi.org/10.3390/pathogens15020208
  3. International Journal of Infectious Diseases (2022). COVID-19 vaccine acceptance in South Asia: a multi-country study. https://doi.org/10.1016/j.ijid.2021.09.056
  4. Infectious Diseases of Poverty. (2021). Quality of life of COVID-19 recovered patients in Bangladesh. https://doi.org/10.1371/journal.pone.0257421
  5. Medical Lab Scientist Awards. (n.d.). Official Awards Platform.
    https://medicallabscientist.com/

AWAD ALI ALI SHEHATA | Microbiology | Best Researcher Award

Published on by Medical Lab Scientist

Prof. Dr. AWAD ALI ALI SHEHATA | Microbiology | Best Researcher Award

Project leader at Technical University of Munich, Germany

Prof. Dr. Awad A. Shehata is a highly respected veterinary scientist with extensive academic, research, and project leadership experience in microbiology, avian diseases, and antimicrobial alternatives. Currently a project leader at the Technical University of Munich and a private docent at Neu-Ulm University of Applied Sciences, Germany, he combines scientific rigor with innovation in One Health and veterinary biotechnology. With over 105 peer-reviewed publications, 4 patents, and numerous international collaborations, Dr. Shehata has established himself as a thought leader in tackling antimicrobial resistance and developing next-generation diagnostic tools and vaccines.

profile

orcid

Education

Dr. Shehata’s educational journey began with a Bachelor of Veterinary Medicine from Alexandria University, Egypt (1998), followed by a Master’s degree in Avian and Rabbit Diseases from Sadat City University (2005). He obtained his Ph.D. in Veterinary Medicine from Leipzig University, Germany (2011), focusing on truncated influenza sequences for vaccination. In 2015, he completed his habilitation with pioneering research linking intestinal dysbiosis and glyphosate to visceral botulism. He later earned advanced certifications, including Dipl. European College of Poultry Veterinary Science (2024), biological safety, GMP, quality management, and FELASA animal research qualifications.

Experience

Spanning over two decades, Dr. Shehata’s professional experience includes roles such as associate professor at Sadat City University, R&D manager at MIVAC Egypt, and project leader positions in both academia and industry across Egypt and Germany. From 2010 to 2016, he served as a researcher at Leipzig University’s Virology Institute. Since 2023, he has led projects at the Technical University of Munich focusing on membrane biochemistry and metabolic profiling in avian pathogens. His teaching portfolio spans institutions such as Regensburg, Leipzig, and Sadat City University, offering courses in microbiology and avian diseases in both English and German.

Research Interest

Dr. Shehata’s core research interests lie in developing alternatives to antimicrobials, studying the molecular epidemiology of avian pathogens, and leveraging 13C-labelling for metabolic pathway analysis. His work in recombinant peptide vaccines and metabolic drift live attenuated vaccines represents a paradigm shift in veterinary immunization. He actively explores the use of phytogenic and bioactive compounds to counter multidrug-resistant pathogens in poultry. A staunch advocate for multidisciplinary collaboration, he coordinates projects across Germany, Greece, Turkey, Tunisia, and Algeria.

Award

Dr. Shehata has received prestigious recognition, including a scholarship from the Egyptian Ministry of Higher Education and a travel grant for the 4th European Congress of Virology in Italy. His leadership in the PRIMA Project (1.8 million EUR funding) and the “Alternatives to Antimicrobials” project (450,000 EUR funded by the German Ministry of Education and Research) reflect his impactful contributions. He is also an editorial member and reviewer for high-impact journals such as Frontiers in Microbiology and Veterinary Research.

Publication

Dr. Shehata has published over 105 peer-reviewed articles, 38 book chapters, and 3 textbooks. Here are 7 selected publications:

Shehata AA, et al. (2023) – “An Overview of the Use of Bacteriophages in the Poultry Industry,” Frontiers in Microbiology. Cited by 30 articles.

Shehata AA, et al. (2022) – “Diversity of Coronaviruses with Attention to SARS-CoV-2,” Animals. Cited by 20 articles.

Shehata AA, et al. (2020) – “Salmonella Enteritidis Vaccine Candidate,” Heliyon. Cited by 18 articles.

Shehata AA, et al. (2020) – “COVID-19 Pandemic Review,” J Clin Med. Cited by 55 articles.

Shehata AA, et al. (2022) – “Probiotics for Gut Health in Poultry,” Microorganisms. Cited by 27 articles.

Shehata AA, et al. (2021) – “Evolution of SARS-CoV-2 Furin Cleavage Sites,” Archives of Virology. Cited by 19 articles.

Shehata AA, et al. (2015) – “Development of Broadly Reactive H5N1 Vaccine,” Vaccine. Cited by 40 articles.

Conclusion

Prof. Dr. Awad A. Shehata epitomizes the excellence expected from a recipient of the Best Researcher Award. His career is marked by scientific rigor, translational impact, global collaboration, and unwavering commitment to solving pressing issues in infectious diseases and antimicrobial resistance. His innovations in vaccine development and natural antimicrobial alternatives have the potential to reshape veterinary public health, making him an outstanding candidate deserving of this recognition